Senseonics Holdings, Inc. reported preliminary unaudited revenue of approximately $14.2 million for Q4 2025 and $35.2 million for the entire year, with cash reserves of about $94.3 million as of December 31, 2025. This filing occurred on January 12, 2026, with a significant 103% increase in the patient base compared to Q4 2024.